DR. DAVID BARBA, M.D.
Medical Practice at Alvarado Rd, San Diego, CA

License number
California G42092
Category
Medical Practice
Type
Neurological Surgery
Address
Address
6645 Alvarado Rd #229, San Diego, CA 92120
Phone
(619) 543-5540
(619) 543-2769 (Fax)
(858) 249-6748

Personal information

See more information about DAVID BARBA at radaris.com
Name
Address
Phone
David Barba
1015 N Belden Ave, Rialto, CA 92376
David Barba
33359 George Smith Rd, Squaw Valley, CA 93675
David Barba
4016 W 104Th St, Inglewood, CA 90304
David Barba
401 W 3Rd St APT 419, San Pedro, CA 90731
David Barba
4491 3Rd St, Guadalupe, CA 93434

Professional information

David Barba Photo 1

In Vivo Gene Transfer Using Implanted Retroviral Producer Cells

US Patent:
6663857, Dec 16, 2003
Filed:
May 13, 1994
Appl. No.:
08/242193
Inventors:
David Barba - San Diego CA
Fred H. Gage - La Jolla CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A01N 6300
US Classification:
424 9321, 424 936, 424 932, 514 44, 4353201
Abstract:
The present invention is directed to methods of transferring therapeutic genes to brain tumor cells in order to kill the cells. In general, the method of the present invention comprises: (1) introducing a retrovirus containing a selectable marker and at least one gene required for its replication into producer cells such that integration of the proviral DNA corresponding to the retrovirus into the genome of the producer cell results in the generation of a modified retrovirus wherein at least one of the genes required for replication of the retrovirus is replaced by the therapeutic gene or genes; (2) selecting producer cells in which the modified retrovirus is incorporated as part of the genome of the producer cells; (3) grafting the producer cells in proximity to the dividing tumor cell in order to infect the tumor cell with the modified retrovirus, thereby transferring the therapeutic gene or genes to the tumor cell; and (4) killing the cells by administering a substance that is metabolized by the therapeutic gene transferred to the tumor cells into a metabolite that kills the cells. Suitable retroviral vectors and methods for generating them, producer cells, and grafting methods are described.


David Barba Photo 2

In Vivo Gene Transfer Using Implanted Retroviral Producer Cells

US Patent:
6663858, Dec 16, 2003
Filed:
Jun 5, 1995
Appl. No.:
08/468411
Inventors:
David Barba - San Diego CA
Fred H. Gage - La Jolla CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A01N 6300
US Classification:
424 9321, 424 936, 424 932, 514 44, 4353201
Abstract:
The present invention is directed to methods of transferring therapeutic genes to brain tumor cells in order to kill the cells. In general, the method of the present invention comprises: (1) introducing a retrovirus containing a selectable marker and at least one gene required for its replication into producer cells such- that integration of the proviral DNA corresponding to the retrovirus into the genome of the producer cell results in the generation of a modified retrovirus wherein at least one of the genes required for replication of the retrovirus is replaced by the therapeutic gene or genes; (2) selecting producer cells in which the modified retrovirus is incorporated as part of the genome of the producer cells; (3) grafting the producer cells in proximity to the dividing tumor cell in order to infect the tumor cell with the modified retrovirus, thereby transferring the therapeutic gene or genes to the tumor cell; and (4) killing the cells by administering a substance that is metabolized by the therapeutic gene transferred to the tumor cells into a metabolite that kills the cells. Suitable retroviral vectors and methods for generating them, producer cells, and grafting methods are described.


David Barba Photo 3

Dr. David Barba, La Jolla CA - MD (Doctor of Medicine)

Specialties:
Neurosurgery
Address:
UCSD Medical Center Sgcl Specs
9350 Campus Point Dr SUITE 2A, La Jolla 92037
(858) 657-8630 (Phone)
UCSD Neurosurgery
212 Dickinson St SUITE B303, San Diego 92103
(619) 543-5540 (Phone)
200 W Arbor Dr, San Diego 92103
(858) 657-8630 (Phone)
4168 Front St, San Diego 92103
(619) 543-5540 (Phone)
Certifications:
Neurosurgery, 1991
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
UCSD Medical Center Sgcl Specs
9350 Campus Point Dr SUITE 2A, La Jolla 92037
200 W Arbor Dr, San Diego 92103
4168 Front St, San Diego 92103
UCSD Neurosurgery
212 Dickinson St SUITE B303, San Diego 92103
Alvarado Hospital
6655 Alvarado Rd, San Diego 92120
Education:
Medical School
Keck School Of Medicine Of The Univ Of Southern California
Graduated: 1979
Los Angeles Co Hospital
Graduated: 1980
University Ca
Graduated: 1985
National Institute Hlth/Natl Institute Neurol&Comm Dis&Stroke
Graduated: 1988
Shinshu University
Graduated: 1984
University Wstrn Ontario Hospital
Graduated: 1986


David Barba Photo 4

In Vivo Transfer Of The Hsv-Tk Gene Implanted Retroviral Producer Cells

US Patent:
5529774, Jun 25, 1996
Filed:
Aug 13, 1991
Appl. No.:
7/744335
Inventors:
David Barba - San Diego CA
Fred H. Gage - La Jolla CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A01N 6300, A01N 4304, A61K 4800, A61K 3170
US Classification:
424 9321
Abstract:
The present invention is directed to methods of transferring therapeutic genes to brain tumor cells in order to kill the cells. In general, the method of the present invention comprises: (1) introducing a retrovirus containing a selectable marker and at least one gene required for its replication into producer cells such that integration of the proviral DNA corresponding to the retrovirus into the genome of the producer cell results in the generation of a modified retrovirus wherein at least one of the genes required for replication of the retrovirus is replaced by the therapeutic gene or genes; (2) selecting producer cells in which the modified retrovirus is incorporated as part of the genome of the producer cells; (3) grafting the producer cells in proximity to the dividing tumor cell in order to infect the tumor cell with the modified retrovirus, thereby transferring the therapeutic gene or genes to the tumor cell; and (4) killing the cells by administering a substance that is metabolized by the therapeutic gene transferred to the tumor cells into a metabolite that kills the cells. Suitable retroviral vectors and methods for generating them, producer cells, and grafting methods are described.


David Barba Photo 5

David Barba, San Diego CA

Specialties:
Neurosurgeon
Address:
200 W Arbor Dr, San Diego, CA 92103
6645 Alvarado Rd, San Diego, CA 92120
Education:
University of Southern California, Keck School of Medicine - Doctor of Medicine*
University of Southern California - Bachelor of Science*
National Institutes of Health-Clinical Center - Fellowship - Neurological Surgery*
University Hospital - Univ. Western Ontario - Fellowship - Neurological Surgery*
Shinshu University Hospital - Fellowship - Microsurgery*
UCSD Healthcare - Residency - Neurological Surgery*
Los Angeles County-USC Medical Center - Internship - Surgery*
Board certifications:
American Board of Neurological Surgery Certification in Neurological Surgery*


David Barba Photo 6

David Barba, San Diego CA

Specialties:
Neurological Surgery, Neurology, Surgery, Medical Oncology
Work:
Ucsd Medical Group
200 W Arbor Dr, San Diego, CA 92103 Va San Diego Healthcare System
3350 La Jolla Village Dr, San Diego, CA 92161 Ucsd Medical Group
9350 Campus Point Dr, La Jolla, CA 92037 Ucsd Medical Group
6645 Alvarado Rd, San Diego, CA 92120
Education:
University of Southern California(1979)